Dallas, Texas-based Taysha Gene Therapies is scheduled to make its debut on the Nasdaq Global Select Market under the symbol "TSHA" on September 24, 2020. Taysha Gene Therapies is a patient-centric gene therapy company developing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system.
from RTT - Biotech https://ift.tt/33LFLNl
via IFTTT
No comments:
Post a Comment